Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
After the emergence of pandemic influenza viruses in 1957, 1968, and 2009, existing seasonal viruses were observed to be replaced in the human population by the novel pandemic strains. We have previously hypothesized that the replacement of seasonal strains was mediated, in part, by a population-scale boost in antibodies specific for conserved regions of the hemagglutinin stalk and the viral neuraminidase. Numerous recent studies have shown the role of stalk-specific antibodies in neutralization of influenza viruses; the finding that stalk antibodies can effectively neutralize virus alters the existing dogma that influenza virus neutralization is mediated solely by antibodies that react with the globular head of the viral hemagglutinin. The present study explores the possibility that stalk-specific antibodies were boosted by infection with the 2009 H1N1 pandemic virus and that those antibodies could have contributed to the disappearance of existing seasonal H1N1 influenza virus strains. To study stalk-specific antibodies, we have developed chimeric hemagglutinin constructs that enable the measurement of antibodies that bind the hemagglutinin protein and neutralize virus but do not have hemagglutination inhibition activity. Using these chimeric hemagglutinin reagents, we show that infection with the 2009 pandemic H1N1 virus elicited a boost in titer of virus-neutralizing antibodies directed against the hemagglutinin stalk. In addition, we describe assays that can be used to measure influenza virus-neutralizing antibodies that are not detected in the traditional hemagglutination inhibition assay.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Updating the accounts: global mortality of the 1918–1920 "Spanish" influenza pandemic.
Johnson, N. P. A. S., & Mueller, J. (2002) · Bulletin of the History of Medicine · doi:10.1353/bhm.2002.0022 · Cited by 1,980 · cited 1×
“In the face of pandemic strains, mortality rates can be quite severe, with an estimation of at least 50 million deaths during the pandemic of 1918 (H1N1; Spanish influenza virus) and several million deaths during the 1957 (H2N2; Asian influenza virus) and 1968 (H3N2; Hong Kong influenza virus) pandemics (2, 3).”
BackgroundAntibody Recognition of a Highly Conserved Influenza Virus Epitope
Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326 · cited 2×
“These antibodies have also been found, at low levels, in individuals after influenza virus vaccination or infection (11, 12, 15, 17, 18).”
BackgroundClaudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Evans, M. J., von Hahn, T., Tscherne, D. M., Syder, A. J., Panis, M., Wölk, B., Hatziioannou, T., McKeating, J. A., Bieniasz, P. D., & Rice, C. M. (2007) · Nature · doi:10.1038/nature05654 · Cited by 1,232 · cited 1×
“The procedure for pseudotype particle production was adapted from previous studies (36).”
MethodCorti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203 · cited 1×
“These antibodies have also been found, at low levels, in individuals after influenza virus vaccination or infection (11, 12, 15, 17, 18).”
BackgroundSui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L.-M., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1566 · Cited by 1,130 · cited 1×
“Vaccination protocols have also been developed that selectively elicit a higher titer of stalk-specific antibody specificities (14).”
BackgroundA Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Ekiert, D. C., Friesen, R. H. E., Bhabha, G., Kwaks, T., Jongeneelen, M., Yu, W., Ophorst, C., Cox, F., Korse, H. J. W. M., Brandenburg, B., et al. (2011) · Science · doi:10.1126/science.1204839 · Cited by 822 · cited 1×
“H3 and H2 subtype HAs fall into distinct phylogenetic groups and have dissimilar stalk structures; although stalk antibodies that neutralize HAs from phylogenetically distinct groups have been identified (9), it is more likely that boosted neuraminidase antibodies, which can have protective activity in vivo, were the…”
BackgroundWrammert, J., Koutsonanos, D., Li, G.-M., Edupuganti, S., Sui, J., Morrissey, M., McCausland, M., Skountzou, I., Hornig, M., Lipkin, W. I., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101352 · Cited by 777
Self-citationRescue of Influenza A Virus from Recombinant DNA
Fodor, E., Devenish, L., Engelhardt, O. G., Palese, P., Brownlee, G. G., & García-Sastre, A. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9679-9682.1999 · Cited by 775
Self-citationThrosby, M., van den Brink, E., Jongeneelen, M., Poon, L. L. M., Alard, P., Cornelissen, L., Bakker, A., Cox, F., van Deventer, E., Guan, Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003942 · Cited by 737
Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
Steel, J., Lowen, A. C., Wang, T. T., Yondola, M., Gao, Q., Haye, K., García-Sastre, A., & Palese, P. (2010) · mBio · doi:10.1128/mbio.00018-10 · Cited by 533
Self-citationOkuno, Y., Isegawa, Y., Sasao, F., & Ueda, S. (1993) · Journal of Virology · doi:10.1128/jvi.67.5.2552-2558.1993 · Cited by 489 · cited 1×
“Indeed, mouse mAb C179, an antibody reactive with the stalk of H1 HA (20), bound to baculovirus-expressed cH6/1 and cH9/1 proteins by ELISA in a dose-dependent manner (SI Materials and Methods and Fig.”
BackgroundCorti, D., Suguitan, A. L., Pinna, D., Silacci, C., Fernandez-Rodriguez, B. M., Vanzetta, F., Santos, C., Luke, C. J., Torres-Velez, F. J., Temperton, N. J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41902 · Cited by 437 · cited 1×
“These antibodies have also been found, at low levels, in individuals after influenza virus vaccination or infection (11, 12, 15, 17, 18).”
BackgroundDavenport, F. M., Hennessy, A. V., Francis, T., & Fabisch, W. T. T. A. O. P. (1953) · Journal of Experimental Medicine · doi:10.1084/jem.98.6.641 · Cited by 399 · cited 1×
“The concept of original antigenic sin (or antigenic imprinting; first postulated by Thomas Francis) argues that, after an initial influenza virus exposure, subsequent infections stimulate immune responses biased to the virus of primary exposure (29).”
BackgroundInduction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
Wei, C.-J., Boyington, J. C., McTamney, P. M., Kong, W.-P., Pearce, M. B., Xu, L., Andersen, H., Rao, S., Tumpey, T. M., Yang, Z.-Y., et al. (2010) · Science · doi:10.1126/science.1192517 · Cited by 337 · cited 1×
“In mice, it has been shown that sequential exposure to antigenically divergent HAs can generate broadly reactive stalk antibodies (13, 16).”
BackgroundWang, T. T., Tan, G. S., Hai, R., Pica, N., Ngai, L., Ekiert, D. C., Wilson, I. A., García-Sastre, A., Moran, T. M., & Palese, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013387107 · Cited by 302 · cited 2×
“Using pooled samples of human sera, we also tested IgG binding to a portion of the HA stem, the long α-helix (LAH), which has been previously shown to mediate protective immunity in mice (21).”
BackgroundMethodSelf-citationThompson, W. W., Comanor, L., & Shay, D. K. (2006) · The Journal of Infectious Diseases · doi:10.1086/507558 · Cited by 284 · cited 1×
“In the United States alone, influenza viruses are thought to contribute to hundreds of thousands of hospitalizations and an average of 30,000 deaths per year (1).”
BackgroundWang, T. T., Tan, G. S., Hai, R., Pica, N., Petersen, E., Moran, T. M., & Palese, P. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000796 · Cited by 278 · cited 3×
“Reactivity of sera of pH1N1-infected adults (n = 9), children not infected with pH1N1 (n = 5), and adults not infected with pH1N1 virus (n = 11) with cH6/1 protein (A), cH9/1 protein (B), the LAH of the HA2 protein (anti-LAH antibody was used as a positive control; C), H5 HA protein (mouse polyclonal serum raised agai…”
BackgroundMethodSelf-citationOriginal Antigenic Sin Responses to Influenza Viruses
Kim, J. H., Skountzou, I., Compans, R., & Jacob, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900398 · Cited by 274
Kashyap, A. K., Steel, J., Oner, A. F., Dillon, M. A., Swale, R. E., Wall, K. M., Perry, K. J., Faynboym, A., Ilhan, M., Horowitz, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801367105 · Cited by 252 · cited 1×
“(17, 23) and the identification of broadly reactive antibodies isolated from individuals that survived H5 virus infection also support this hypothesis.”
BackgroundSelf-citationAttenuation of Equine Influenza Viruses through Truncations of the NS1 Protein
Quinlivan, M., Zamarin, D., García-Sastre, A., Cullinane, A., Chambers, T., & Palese, P. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8431-8439.2005 · Cited by 241 · cited 1×
“Briefly, different components of the cHA were amplified by PCR with primers containing Sap I sites, digested with Sap I, and cloned into the Sap I sites of the pDZ plasmid (34).”
MethodSelf-citationVitamin B 6 Is Required for Full Motility and Virulence in Helicobacter pylori
Grubman, A., Phillips, A., Thibonnier, M., Kaparakis-Liaskos, M., Johnson, C., Thiberge, J.-M., Radcliff, F. J., Ecobichon, C., Labigne, A., de Reuse, H., et al. (2010) · mBio · doi:10.1128/mbio.00112-10 · Cited by 216
Manicassamy, B., Medina, R. A., Hai, R., Tsibane, T., Stertz, S., Nistal-Villán, E., Palese, P., Basler, C. F., & García-Sastre, A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000745 · Cited by 196 · cited 1×
“It is possible that the immunological mechanisms that bias one’s response to early exposures to virus may be, in part, explained by the induction of stalk-specific antibodies (30, 31).”
BackgroundSelf-citationThe emergence of pandemic influenza viruses
Guan, Y., Vijaykrishna, D., Bahl, J., Zhu, H., Wang, J., & Smith, G. J. D. (2010) · Protein & Cell · doi:10.1007/s13238-010-0008-z · Cited by 178 · cited 1×
“In the face of pandemic strains, mortality rates can be quite severe, with an estimation of at least 50 million deaths during the pandemic of 1918 (H1N1; Spanish influenza virus) and several million deaths during the 1957 (H2N2; Asian influenza virus) and 1968 (H3N2; Hong Kong influenza virus) pandemics (2, 3).”
BackgroundMeier, S., Güthe, S., Kiefhaber, T., & Grzesiek, S. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.09.079 · Cited by 172 · cited 1×
“For generation of the baculotransfer plasmids, cH6/1 and cH9/1 were amplified by PCR, cut with BamHI and NotI, and cloned in frame into a modified pFastBac (Invitrogen) baculotransfer vector that harbors a C-terminal T4 phage fold-on and a 6-his tag (35).”
MethodSchulman, J. L., & Kilbourne, E. D. (1969) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.63.2.326 · Cited by 154 · cited 1×
“These antibodies are typically measured using the classical HI assay (22).”
MethodSkountzou, I., Koutsonanos, D. G., Kim, J. H., Powers, R., Satyabhama, L., Masseoud, F., Weldon, W. C., Martin, M. D. P., Mittler, R. S., Compans, R., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000091 · Cited by 134 · cited 1×
“It is possible that the immunological mechanisms that bias one’s response to early exposures to virus may be, in part, explained by the induction of stalk-specific antibodies (30, 31).”
BackgroundInfluenza B Virus NS1-Truncated Mutants: Live-Attenuated Vaccine Approach
Hai, R., Martínez‐Sobrido, L., Fraser, K. A., Ayllón, J., García‐Sastre, A., & Palese, P. (2008) · Journal of Virology · doi:10.1128/jvi.01213-08 · Cited by 128 · cited 1×
“cHA constructs with the stalk of A/Puerto Rico/8/1934 (PR8) containing the globular head domain from either A/mallard/Sweden/81/02 (cH6/1) virus or A/ guinea fowl/Hong Kong/WF10/99 (cH9/1) viruses were generated using methods previously described (32, 33).”
MethodSelf-citationWhy Do Influenza Virus Subtypes Die Out? A Hypothesis
Palese, P., & Wang, T. T. (2011) · mBio · doi:10.1128/mbio.00150-11 · Cited by 115 · cited 4×
“This finding was not particularly surprising given the disappearance of other circulating influenza virus strains after the emergence of a novel pandemic virus in 1957 and 1968 (5, 6).”
BackgroundSelf-citationOkuno, Y., Matsumoto, K., Isegawa, Y., & Ueda, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.517-520.1994 · Cited by 104
Kashyap, A. K., Steel, J., Rubrum, A. M., Estellés, A., Briante, R., Ilyushina, N. A., Li, X., Swale, R. E., Faynboym, A. M., Foreman, P. K., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000990 · Cited by 74 · cited 2×
“These antibodies have also been found, at low levels, in individuals after influenza virus vaccination or infection (11, 12, 15, 17, 18).”
BackgroundSelf-citationAn enzymatic virus-like particle assay for sensitive detection of virus entry
Tscherne, D. M., Manicassamy, B., & García‐Sastre, A. (2009) · Journal of Virological Methods · doi:10.1016/j.jviromet.2009.10.020 · Cited by 70
Self-citationSeasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine
Chen, G. L., Lau, Y.-F., Lamirande, E. W., McCall, A. W., & Subbarao, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009908108 · Cited by 60
Wang, T. T., & Palese, P. (2011) · Science · doi:10.1126/science.1210724 · Cited by 25
Self-citation
Cited by
The human antibody response to influenza A virus infection and vaccination
Krammer, F. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0143-6 · Cited by 796
Self-citationInterspecies transmission and emergence of novel viruses: lessons from bats and birds
Chan, J. F.-W., To, K. K.-W., Tse, H., Jin, D.-Y., & Yuen, K.-Y. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.05.005 · Cited by 616
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
Impagliazzo, A., Milder, F., Kuipers, H., Wagner, M. V., Zhu, X., Hoffman, R. M. B., van Meersbergen, R., Huizingh, J., Wanningen, P., Verspuij, J., et al. (2015) · Science · doi:10.1126/science.aac7263 · Cited by 600
Advances in the development of influenza virus vaccines
Krammer, F., & Palese, P. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4529 · Cited by 597
Self-citationBroadly Neutralizing Antiviral Antibodies
Corti, D., & Lanzavecchia, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095916 · Cited by 475
Metadata
- Authors
- Pica, N., Hai, R., Krammer, F., Wang, T. T., Maamary, J., Eggink, D., Tan, G. S., Krause, J. C., Moran, T., Stein, C. R., Banach, D., Wrammert, J., Belshe, R. B., García-Sastre, A., & Palese, P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2012-01-30
- Volume
- 109
- Issue
- 7
- Pages
- 2573-2578
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2026370792
- Cited by
- 250
- References
- 34
- FWCI
- 23.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.